Kimberly-Clark is selling its Kleenex and tissue businesses outside North America to Brazilian company Suzano for about $3.5 billion, shifting focus to more profitable areas.

The deal boosts Suzano’s global tissue market presence.

Analysts give Kimberly-Clark (NYSE: KMB) an average price target of $144.13, indicating a modest 4.12% upside from its current price of $138.43.

Brokerage firms rate the stock a “Hold” with an average recommendation of 2.8.

GuruFocus estimates a GF Value of $131.94, suggesting a potential downside, Guru Focus has reported.

Investors are advised to weigh both forecasts and valuations when evaluating the stock.

Written by B.C. Begley